# Terumo Cardiovascular Systems Corporation - Inspection Records Source: https://www.keypedia.com/companies/terumo-cardiovascular-systems-corporation/27d34ede-00fd-45aa-b5e4-6158781b6854 > Inspection records and compliance data for Terumo Cardiovascular Systems Corporation in Ann Arbor, Michigan. Access full analysis and detailed observations. --- ## Details - Name: Terumo Cardiovascular Systems Corporation - FEI Number: 1828100 - City: Ann Arbor - State: Michigan - Country Name: United States - Address Line 1: 6200 Jackson Rd - Zip Code: 48103 - Facility Type: Medical Device Manufacturer ## Related Documents - [FDA Inspection 1147794 - Terumo Cardiovascular Systems Corporation - 2021-07-14](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/a272af14-a768-43d8-9f42-465fade7db48) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2021 - [FDA Inspection 1147794 - Terumo Cardiovascular Systems Corporation - 2021-07-14](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/d3bc670c-ee8b-4ca0-bf7e-2884818750f7) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2021 - [FDA Inspection 1111814 - Terumo Cardiovascular Systems Corporation - 2019-10-11](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/2db78055-c313-4dd4-ae58-8e71a00b5f2f) — classification: No Action Indicated (NAI), source: FDA, date: October 11, 2019 - [FDA Inspection 1111814 - Terumo Cardiovascular Systems Corporation - 2019-10-11](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/176bc038-5a57-4ac1-b1f1-6532ac8b1827) — classification: No Action Indicated (NAI), source: FDA, date: October 11, 2019 - [FDA Inspection 1031879 - Terumo Cardiovascular Systems Corporation - 2017-10-03](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/bdd53816-f3e5-49dc-926b-dece9d04ed99) — classification: No Action Indicated (NAI), source: FDA, date: October 3, 2017 - [FDA Inspection 1031879 - Terumo Cardiovascular Systems Corporation - 2017-10-03](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/a5675de2-cd12-42e4-9e26-859a3a5c8c5a) — classification: No Action Indicated (NAI), source: FDA, date: October 3, 2017 - [FDA Inspection 996655 - Terumo Cardiovascular Systems Corporation - 2016-12-07](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/cd014f40-ac3e-45db-b57e-5e1c47872878) — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2016 - [FDA Inspection 996655 - Terumo Cardiovascular Systems Corporation - 2016-12-07](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/64f04db4-1c79-4512-8652-d8741253cffe) — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2016 - [FDA Inspection 971672 - Terumo Cardiovascular Systems Corporation - 2016-05-13](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/ecb01391-2ec1-4bc7-aa9a-991b7fafb387) — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2016 - [FDA Inspection 971672 - Terumo Cardiovascular Systems Corporation - 2016-05-13](https://www.keypedia.com/records/fda_inspections/terumo-cardiovascular-systems-corporation/e8569fdf-d66a-4eb1-896b-dac66f193919) — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2016 - [483 - Terumo Cardiovascular Systems Corporation - 2012-09-28](https://www.keypedia.com/records/483/terumo-cardiovascular-systems-corporation/ab62c2e6-8cca-4df8-b7db-e7bde0dd7802) — source: FDA, date: September 28, 2012 - [483 - Terumo Cardiovascular Systems Corporation - 2010-03-29](https://www.keypedia.com/records/483/terumo-cardiovascular-systems-corporation/91358452-97b4-4c1b-8281-77aced3673c6) — source: FDA, date: March 29, 2010 - [483 - Terumo Cardiovascular Systems Corporation - 2008-08-11](https://www.keypedia.com/records/483/terumo-cardiovascular-systems-corporation/b54a6646-bf21-4eb7-a0b9-364383448e24) — source: FDA, date: August 11, 2008 - [483 - Terumo Cardiovascular Systems Corporation - 2005-12-09](https://www.keypedia.com/records/483/terumo-cardiovascular-systems-corporation/178619f8-e041-4f9e-acf9-78c150503b95) — source: FDA, date: December 9, 2005 - [483 - Terumo Cardiovascular Systems Corporation - 2004-05-18](https://www.keypedia.com/records/483/terumo-cardiovascular-systems-corporation/a921663c-9a8e-413a-aab8-c4f5bd9eab7d) — source: FDA, date: May 18, 2004 ## Related Companies - [Bactolac Pharmaceutical, Inc.](https://www.keypedia.com/companies/bactolac-pharmaceutical-inc/6448ddc2-938d-490b-960d-d958c552f9bb) - [Setton Pistachio of Terra Bella, Inc.](https://www.keypedia.com/companies/setton-pistachio-of-terra-bella-inc/c550441e-26d7-4e4e-a3d8-9d7c4a840869) - [Fagron, Inc](https://www.keypedia.com/companies/fagron-inc/32e6861b-84b5-4daa-a189-8f2470413595) - [Lymol Medical Corporation](https://www.keypedia.com/companies/lymol-medical-corporation/a98bac62-27b5-4afb-897b-aed3e10e1d9c) - [Stason Pharmaceuticals, Inc.](https://www.keypedia.com/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae) - [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928) - [Neurolumen LLC](https://www.keypedia.com/companies/neurolumen-llc/2e53eb6e-6247-4069-ade9-cef49b1b8f04) - [Northwest Eye Design, LLC](https://www.keypedia.com/companies/northwest-eye-design-llc/eb08662b-92e1-4cb6-9dbf-f780fbf30a22) - [Daiichi Sankyo, Inc.](https://www.keypedia.com/companies/daiichi-sankyo-inc/fd789c74-6b2b-43fb-800d-326eceeb1aea) - [Innovative Med Inc.](https://www.keypedia.com/companies/innovative-med-inc/aee44d09-6f76-45aa-b532-ac3501972fd9) ## Related Officers - [William D. Timdey](https://www.keypedia.com/people/william-d-timdey/077ad007-0018-43d4-9140-aaa41be323f4) - [Executive Director and President](https://www.keypedia.com/people/benjamin-j-smith/e1af43c9-7d34-4f17-af95-9e6aff5897d5) - [Medical Device Senior Operations Officer at FDA](https://www.keypedia.com/people/thomas-a-peter/48a36892-cc03-42bb-8960-978d18f2147a) - [Investigator](https://www.keypedia.com/people/patrick-cummings/1fce2fdc-9207-480a-bb4f-ffe7bbf65094) - [Ryan Zettle, PharmD, MBA](https://www.keypedia.com/people/ryan-zettle-pharmd-mba/d14fa18c-7da8-4f04-bdf2-69ca3b6541d0) - [Real Estate Investor](https://www.keypedia.com/people/charles-spyr/efee02df-a1bf-42b2-9095-31e9863bc32a)